HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Viral antibodies in multiple sclerosis. A nationwide co-twin study.

Abstract
Serum viral antibody titers against 21 viruses were studied in 19 of 23 same-sex twin pairs with multiple sclerosis derived from the Finnish Twin Cohort. Thorough neurologic examinations showed two monozygotic pairs to be concordant, whereas all dizygotic pairs were discordant. Special attention was given to measles, mumps, and rubella viruses, against which the antibody levels were determined with the complement fixation, hemagglutination inhibition, hemolysis-ingel, and enzyme immunoassay methods. Epstein-Barr virus antibody levels were determined by enzyme assay. In pairwise comparisons, the measles, mumps, and Epstein-Barr virus-IgG antibody levels were more often elevated in the patients with multiple sclerosis, compared with the healthy co-twins. The same antibody levels were more often above the median in the diseased twin, compared with the healthy twin, but the difference was not significant. No human T-cell lymphotropic virus type I antibodies were found in any of the individuals examined. The total IgG, IgA, and IgM levels did not differ between the diseased and healthy subjects. The HLA types, severity of the disease, and cell-mediated immunity parameters did not influence antibody levels.
AuthorsE Kinnunen, M Valle, L Piirainen, M Kleemola, M L Kantanen, J Juntunen, M Klockars, M Koskenvuo
JournalArchives of neurology (Arch Neurol) Vol. 47 Issue 7 Pg. 743-6 (Jul 1990) ISSN: 0003-9942 [Print] United States
PMID2162658 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Antibodies, Viral (analysis, genetics)
  • Diseases in Twins
  • Finland
  • Herpesvirus 4, Human (immunology)
  • Humans
  • Immunoenzyme Techniques
  • Measles virus (immunology)
  • Multiple Sclerosis (genetics, immunology)
  • Mumps virus (immunology)
  • Rubella virus (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: